ABIVAX (EPA:ABVX) | Finanzwire

BRIEF

published on 05/14/2025 at 18:05, 8 months 16 days ago

ABIVAX: Number of shares and voting rights as of April 30, 2025

Voting Rights Actions Abivax AMF Regulations Financial Transparency
BRIEF

published on 04/29/2025 at 22:10, 9 months 1 day ago

Abivax Completes Enrollment for Phase 3 Ulcerative Colitis Trials

Abivax Obefazimod Ulcerative Colitis Phase 3 Trials Clinical Enrollment
PRESS RELEASE

published on 04/29/2025 at 22:05, 9 months 1 day ago

Abivax Announces Completion of Enrollment for the Phase 3 ABTECT Trials in Patients with Moderately to Severely Active Ulcerative Colitis
Abivax completes enrollment for Phase 3 ABTECT Trials in patients with active ulcerative colitis. Top-line results expected in Q3 2025, NDA submission planned for H2 2026

Abivax Ulcerative Colitis Phase 3 ABTECT Trials NDA Submission
BRIEF

published on 04/22/2025 at 22:10, 9 months 8 days ago

Abivax: Terms of the Annual General Meeting and outlook for 2025

Biotechnology Abivax Clinical Trials Investment General Meeting 2025
BRIEF

published on 04/22/2025 at 22:05, 9 months 8 days ago

Abivax welcomes Dr. Dominik Höchli to its Board of Directors

Board Of Directors Abivax Phase 3 Immunology Dominik Höchli
PRESS RELEASE

published on 04/22/2025 at 22:05, 9 months 8 days ago

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
Abivax announces details of Annual General Meeting on June 6, 2025, in Paris as it progresses towards key 2025 milestones, including Phase 3 ABTECT trials

Annual General Meeting Abivax Clinical-stage Biotechnology Phase 3 ABTECT Trials 2025 Milestones
PRESS RELEASE

published on 04/22/2025 at 22:00, 9 months 8 days ago

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
Abivax appoints Dominik Höchli, MD to Board of Directors, bringing extensive immunology expertise ahead of key Phase 3 data readout in ulcerative colitis in Q3 2025

Board Of Directors Abivax Ulcerative Colitis Dominik Höchli Phase 3 Data Readout
BRIEF

published on 04/18/2025 at 18:05, 9 months 12 days ago

ABIVAX: Share Capital and Voting Rights as of March 31, 2025

Euronext Paris Share Capital Voting Rights Actions Abivax
BRIEF

published on 04/18/2025 at 18:05, 9 months 12 days ago

ABIVAX: Details of Share Capital and Voting Rights as of March 31, 2025

Euronext Paris Share Capital Voting Rights Biotechnology Abivax
BRIEF

published on 03/27/2025 at 18:05, 10 months 3 days ago

ABIVAX: Update of share capital and voting rights

Share Capital Voting Rights Biotechnology AMF Abivax

Published on 01/31/2026 at 03:15, 1 hour 58 minutes ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 2 hours 53 minutes ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 3 hours 33 minutes ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 5 hours 13 minutes ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 6 hours 13 minutes ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 02:45, 2 hours 28 minutes ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 7 hours 13 minutes ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 9 hours 3 minutes ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 20:09, 9 hours 3 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches
Published on 01/30/2026 at 20:07, 9 hours 6 minutes ago

Aroundtown SA successfully issued AUD 600 million bonds in two tranches

View all EQS

Published on 01/30/2026 at 17:45, 11 hours 28 minutes ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 08:00, 21 hours 13 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 1 day 11 hours ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 11 hours ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 11 hours ago

Cegedim generated LFL revenue growth of 1.1% in 2025

View all LES ECHOS COMFI WIRE

News